Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16429615 | 0.85 | IDO1 (0.53) | IDO1TDP1GABRA1GABRB2HPGD | |
| SCHEMBL2204567 | 0.84 | GABRA1 (0.43) | IDO1TDP1GABRA1GABRB2HPGD | |
| SCHEMBL2962223 | 0.82 | TDP1 (0.57) | IDO1TDP1HPGDMAPTKMT2A | |
| SCHEMBL16961898 | 0.80 | TDP1 (0.60) | IDO1TDP1HPGDGAAMAPT | |
| SCHEMBL11411652 | 0.79 | IDO1 (0.79) | IDO1GAAALDH1A1 | |
| SCHEMBL4229462 | 0.79 | TSHR (0.48) | IDO1TDP1GABRA1GABRB2HPGD | |
| SCHEMBL1028965 | 0.77 | SGMS2 (0.43) | IDO1TDP1GABRA1GABRB2HPGD | |
| SCHEMBL5323369 | 0.77 | HPGD (0.49) | TDP1HPGDGAAMAPTKMT2A | |
| SCHEMBL10762934 | 0.77 | ALDH1A1 (0.49) | IDO1TDP1GABRA1GABRB2HPGD | |
| SCHEMBL11576066 | 0.77 | SGMS2 (0.43) | IDO1TDP1GABRA1GABRB2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9242944-B2 | Potent analogues of the C-Myc inhibitor 10074-G5 with improved cell permeability | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2016-01-26 | — | — | US | disclosed |
| CN-105102451-A | N-phenyl-carboxamide derivatives and their use as medicaments for the treatment of hepatitis b | JANSSEN R & D IRELAND | 2015-11-25 | — | — | CN | disclosed |
| US-20140296307-A1 | POTENT ANALOGUES OF THE C-MYC INHIBITOR 10074-G5 WITH IMPROVED CELL PERMEABILITY | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2014-10-02 | — | — | US | disclosed |
| US-8653273-B2 | Potent non-urea inhibitors of soluble epoxide hydrolase | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2014-02-18 | — | — | US | disclosed |
| US-8563588-B2 | Imidazolone derivatives, method for the preparation thereof and biological applications | UNIVERSITE DE RENNES 1 (FR) | 2013-10-22 | — | — | US | disclosed |
| US-8198458-B2 | Non-nucleoside reverse transcriptase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-06-12 | — | — | US | disclosed |
| US-8198458-B2 | Non-nucleoside reverse transcriptase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-06-12 | — | — | US | disclosed |
| US-20120059162-A1 | FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION | ONCOTHERAPY SCIENCE, INC. (JP) | 2012-03-08 | — | — | US | disclosed |
| US-20120059162-A1 | FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION | ONCOTHERAPY SCIENCE, INC. (JP) | 2012-03-08 | — | — | US | disclosed |
| US-20110077381-A1 | NOVEL NPR-B AGONISTS | ALCON RESEARCH, LTD. (US) | 2011-03-31 | — | — | US | disclosed |
| US-6214954-B1 | HOMO OR COPOLYMERIZING AN OLEFIN WITH POLYMERIZATION CATALYST COMPRISING A TRANSITION METAL COMPOUND, CYCLOPENTADIENYL RING CONTAINING LIGAND AND A CHELATING LIGAND, PRODUCES POLYMER WITH NARROW MOLECULAR WEIGHT DISTRIBUTION AND UNIFORMITY | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 2001-04-10 | — | — | US | disclosed |
| EP-0798313-B1 | OLEFIN POLYMERIZATION CATALYST | ASAHI CHEMICAL IND (JP) | 2001-03-21 | — | — | EP | disclosed |
| CN-1169736-A | Catalyst for olefin polymerization | ASAHI CHEMICAL IND (JP) | 1998-01-07 | — | — | CN | disclosed |
| EP-0798313-A1 | OLEFIN POLYMERIZATION CATALYST | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1997-10-01 | — | — | EP | disclosed |
| EP-0427572-B1 | Process for preparing N-alkylaminophenols and N,N-dialkylaminophenols | SUMITOMO CHEMICAL CO (JP) | 1994-04-27 | — | — | EP | disclosed |
| EP-0411817-B1 | Process for preparing N-alkyl-substituted aminophenols | SUMITOMO CHEMICAL CO (JP) | 1994-04-06 | — | — | EP | disclosed |
| US-5276193-A | Reductive alkylation, addition of carboxylic acid to prevent by-product formation | SUMITOMO CHEMICAL CO., LTD. (JP) | 1994-01-04 | — | — | US | disclosed |
| US-5202485-A | Catalytic reductive alkylation of aminophenol using aldehyde or ketone | SUMITOMO CHEMICAL CO., LTD. (JP) | 1993-04-13 | — | — | US | disclosed |
| EP-0427572-A1 | Process for preparing N-alkylaminophenols and N,N-dialkylaminophenols | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-05-15 | — | — | EP | disclosed |
| EP-0411817-A2 | Process for preparing N-alkyl-substituted aminophenols | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059162-A1 | FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION | NR0B1, GRK7, NR5A2 | IDO1 3443/4885TDP1 3967/4885GABRA1 762/4885 |
| US-20110077381-A1 | NOVEL NPR-B AGONISTS | NPR1, NPR3, NPBWR1 | IDO1 1680/4885TDP1 3361/4885GABRA1 318/4885 |
| US-20140296307-A1 | POTENT ANALOGUES OF THE C-MYC INHIBITOR 10074-G5 WITH IMPROVED CELL PERMEABILITY | MYC, MYCBP, MKI67 | IDO1 3214/4885TDP1 3756/4885GABRA1 2956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.